Breaking News Instant updates and real-time market news.

CSRA

CSRA

$31.08

0.64 (2.10%)

, REGN

Regeneron

$480.43

14.41 (3.09%)

09:55
06/05/17
06/05
09:55
06/05/17
09:55

Early notable gainers among liquid option names on June 5th

Notable gainers among liquid option names this morning include CSRA (CSRA) $31.14 +0.70, Regeneron (REGN) $488.53 +8.08, Intercontinental Exchange (ICE) $61.20 +0.95, State Street (STT) $83.73 +1.09, and Activision Blizzard (ATVI) $60.42 +0.78.

CSRA

CSRA

$31.08

0.64 (2.10%)

REGN

Regeneron

$480.43

14.41 (3.09%)

ICE

IntercontinentalExchange

$60.65

0.33 (0.55%)

STT

State Street

$84.03

1.35 (1.63%)

ATVI

Activision Blizzard

$59.65

0.09 (0.15%)

  • 07

    Jun

CSRA CSRA
$31.08

0.64 (2.10%)

03/06/17
COWN
03/06/17
DOWNGRADE
COWN
Market Perform
CSRA downgraded to Market Perform from Outperform at Cowen
Cowen analyst Gautam Khanna downgraded CSRA to Market Perform and lowered its price target to $32 from $35 citing lack of near-term catalysts, flattish FY18 adjusted/earnings, and sizable re-competes over the next year that reduce FY19+ visibility.
03/16/17
VERT
03/16/17
INITIATION
VERT
Hold
CSRA initiated with a Hold at Vertical Research
Vertical Research analyst Krishna Sinha started CSRA with a Hold rating.
04/05/17
04/05/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Burlington Stores (BURL) initiated with an Outperform at William Blair. 2. Booz Allen (BAH) was initiated with an In Line while CSRA (CSRA) was initiated with an Outperform at Evercore ISI. 3. Guidance Software (GUID) initiated with an Overweight at Piper Jaffray. 4. Acacia Communications (ACIA) initiated with a Neutral at B. Riley. 5. Keysight Technologies (KEYS) initiated with a Buy at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/04/17
EVER
04/04/17
INITIATION
Target $34
EVER
Outperform
CSRA initiated with an Outperform at Evercore ISI
Evercore ISI analyst Rayna Kumar initiated CSRA with an Overweight and a $34 price target citing industry leading EBITDA margins driven by exposure to high margin, fixed price contracts, a next generation IT focus, and financial discipline.
REGN Regeneron
$480.43

14.41 (3.09%)

05/23/17
JEFF
05/23/17
NO CHANGE
Target $418
JEFF
Hold
Regeneron approval expected, but positive, says Jefferies
Jefferies analyst Biren Amin says that while the FDA approval of Regeneron's (REGN) Kevzara for the treatment of adult patients with moderate to severe active rheumatoid arthritis was expected, it is a positive. The label is in line with expectations and includes a risk of serious infections similar to Humira's (HUM) label, Amin tells investors in a research note. He notes that Regeneron disclosed a $39,000 wholesale acquisition cost for Kevzara, which is 30% lower than TNF competitors. The analyst has a Hold rating on Regeneron with a $418 price target.
05/05/17
LEER
05/05/17
NO CHANGE
Target $493
LEER
Outperform
Regeneron price target raised to $493 from $448 at Leerink
Leerink analyst Geoffrey Porges raised his price target for Regeneron to $493 from $448 following quarterly results, and given the strength of peer company multiples and greater conviction about long-term profitability. The analyst reiterates an Outperform rating on the shares.
05/05/17
ADAM
05/05/17
UPGRADE
Target $484
ADAM
Buy
Regeneron upgraded to Buy at Canaccord
As reported previously, Canaccord analyst John Newman upgraded Regeneron to Buy from Hold. The analyst cited the strong investor sentiment toward the Dupixent launch, which he believes will drive the shares higher into Q2 and Q3 earnings. He also believes there will be less focus on Eylea revenues, despite slowing growth. Newman raised his price target to $484 from $375 on Regeneron shares.
05/05/17
UBSW
05/05/17
NO CHANGE
Target $489
UBSW
Buy
Regeneron price target raised to $489 from $446 at UBS
UBS analyst Carter Gould raised his price target on Regeneron to $489 from $446 following Q1 results. The analyst lowered his Eylea U.S. sales estimates based on Q1 trends, but he saw positives in the Dupixent update, including strong demand in atopic dermatitis. Also, the company has seen positive proof-of-concept data in eosinophilic esophagitis, which he noted was not in Street models. Gould reiterated his Buy rating on Regeneron shares.
ICE IntercontinentalExchange
$60.65

0.33 (0.55%)

08/04/16
UBSW
08/04/16
NO CHANGE
Target $314
UBSW
Buy
IntercontinentalExchange price target raised to $314 from $279 at UBS
UBS raised its price target on IntercontinentalExchange to $314 from $279 as they believe the company is clicking on all cylinders. The firm cited strong Market Data growth, share repurchases, and growth in non-transactional revenues. UBS reiterated its Buy rating on IntercontinentalExchange shares.
09/23/16
RBCM
09/23/16
NO CHANGE
RBCM
CBOE 'likely in the cross-hairs' of bigger peers, says RBC Capital
RBC Capital analyst Andrew Bond said he thinks the strategic risk of a deal whereby CBOE (CBOE) buys Bats Global Markets (BATS), as it has been reported to be in talks to do, outweighs the potential reward. However, he also believe CBOE's relatively small size, limited regulatory risk, clean balance sheet, and strong organic growth make it an attractive target for its largest exchange peers, such as IntercontinentalExchange (ICE) and CME Group (CME). A combined CBOE/BATS would be more difficult to acquire, so if CBOE is to be acquired, "the time is now," added Bond.
03/30/17
RBCM
03/30/17
INITIATION
RBCM
Sector Perform
IntercontinentalExchange resumed with a Sector Perform at RBC Capital
RBC Capital analyst Peter Lenardos resumed coverage on IntercontinentalExchange with a $60 price target saying shares are fairly valued.
STT State Street
$84.03

1.35 (1.63%)

06/05/17
UBSW
06/05/17
UPGRADE
Target $92
UBSW
Buy
State Street upgraded to Buy from Neutral at UBS
UBS analyst Brennan Hawken upgraded State Street to Buy and raised his price target for the shares to $92 from $86. The analyst believes investor concerns about increased competitive pressure has brought an attractive buying opportunity. After meeting with management, Hawken has greater confidence in the earnings outlook for the company's European business.
05/26/17
05/26/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Immunomedics (IMMU) initiated with an Outperform at Cowen. 2. Sherwin-Williams (SHW) initiated with a Hold at Jefferies. 3. State Street (STT) reinstated with a Neutral at BofA/Merrill. 4. Zoetis (ZTS) initiated with a Buy at CL King. 5. BioDelivery Sciences (BDSI) initiated with a Buy at H.C. Wainwright. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/26/17
BOFA
05/26/17
INITIATION
Target $88
BOFA
Neutral
State Street reinstated with a Neutral at BofA/Merrill
BofA/Merrill analyst Michael Carrier reinstated coverage on State Street with a Neutral and a $88 price target citing its lower growth outlook.
04/13/17
DBAB
04/13/17
NO CHANGE
DBAB
Deutsche recommends long BNY Mellon, short State Street pair trade
Ahead of earnings reports from the brokers, asset managers and exchanges, Deutsche Bank analyst Brian Bedell recommends a pair trade to go long BNY Mellon (BK) versus short State Street (STT), as he sees NY Mellon narrowly beating consensus while he expects State Street to post a slight miss and also predicts downward revisions to 2017. Bedell keeps a Buy rating on BNY Mellon and a Hold rating on State Street.
ATVI Activision Blizzard
$59.65

0.09 (0.15%)

05/12/17
PIPR
05/12/17
NO CHANGE
PIPR
April NPD video game software sales rose 9%, says Piper Jaffray
Piper Jaffray analyst Michael Olson notes April NPD video game software sales were up 9% year-over-year, helped by the launch of Nintendo's (NTDOY) Switch console Top titles for the month included Nintendo's The Legend of Zelda: Breadth of the Wild and Mario Kart 8, Olson tells investors in a research note. The April numbers are less material since Activision Blizzard (ATVI) and Electronic Arts (EA) recently announced guidance for the June quarter, the analyst adds. He keeps an Overweight rating on those two names along with Take-Two Interactive (TTWO).
05/05/17
05/05/17
NO CHANGE

Activision Blizzard guidance appears conservative, says Pacific Crest
Pacific Crest analysts Evan Wingren and Andy Hargreaves say that Activision Blizzard's implied guidance appears to be conservative. The analysts think that the company has multiple potential positive catalysts for the rest of 2017 and is poised to benefit from the proliferation of digital games. They keep a $60 price target and an Overweight rating on the shares.
05/05/17
OPCO
05/05/17
NO CHANGE
Target $60
OPCO
Outperform
Activision Blizzard price target raised to $60 from $53 at Oppenheimer
Oppenheimer analyst Andrew Uerkwitz raised his price target for Activision Blizzard to $60 from $53 following quarterly results. The analyst believes the company has proven, and will be able to continue to execute on its strategy to drive player engagement and investments through high quality content. Uerkwitz also thinks Activision Blizzard has untapped revenue growth from eSports, advertising, and cross-platform applications of its IP assets. He reiterates an Outperform rating on the shares.
05/05/17
WEDB
05/05/17
NO CHANGE
WEDB
Activision Blizzard price target raised to $62.50 from $53 at Wedbush
Wedbush analyst Michael Pachter raised his price target on Activision after the company reported stronger than expected Q1 results. The analyst thinks that the company's 2017 guidance is conservative and believes that its EPS could reach $3 by 2018. He keeps an Outperform rating on the stock.

TODAY'S FREE FLY STORIES

VIAB

Viacom

$26.57

0.31 (1.18%)

, CHTR

Charter

$357.84

-4.76 (-1.31%)

12:38
10/18/17
10/18
12:38
10/18/17
12:38
Recommendations
Viacom, Charter analyst commentary  »

Viacom carriage deal…

VIAB

Viacom

$26.57

0.31 (1.18%)

CHTR

Charter

$357.84

-4.76 (-1.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

CMG

Chipotle

$321.62

-7.68 (-2.33%)

12:36
10/18/17
10/18
12:36
10/18/17
12:36
Hot Stocks
Chipotle slides after analyst says sell on labor costs concerns »

Shares of Chipotle…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

DYN

Dynegy

$9.53

0.085 (0.90%)

12:35
10/18/17
10/18
12:35
10/18/17
12:35
Options
Dynegy put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMRN

BioMarin

$93.54

-1.12 (-1.18%)

12:34
10/18/17
10/18
12:34
10/18/17
12:34
Hot Stocks
BioMarin says Pegvaliase application remains on track »

BioMarin said its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 26

    Oct

  • 06

    Nov

  • 28

    Feb

BMRN

BioMarin

$93.54

-1.12 (-1.18%)

12:32
10/18/17
10/18
12:32
10/18/17
12:32
Hot Stocks
BioMarin provides update on development portfolio »

BioMarin updated the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 26

    Oct

  • 06

    Nov

  • 28

    Feb

IBM

IBM

$160.45

13.905 (9.49%)

, ABT

Abbott

$56.00

0.9449 (1.72%)

12:30
10/18/17
10/18
12:30
10/18/17
12:30
General news
On The Fly: Top stock stories at midday »

Stocks opened sharply…

IBM

IBM

$160.45

13.905 (9.49%)

ABT

Abbott

$56.00

0.9449 (1.72%)

ANTM

Anthem

$193.45

6.19 (3.31%)

CVS

CVS Health

$74.11

1.475 (2.03%)

CREE

Cree

$29.34

0.06 (0.20%)

RXDX

Ignyta

$14.35

0.95 (7.09%)

AGN

Allergan

$188.67

-9.11 (-4.61%)

SVU

Supervalu

$17.73

-1.65 (-8.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 20

    Oct

  • 22

    Oct

  • 23

    Oct

  • 25

    Oct

  • 01

    Nov

  • 06

    Nov

  • 06

    Nov

  • 15

    Nov

  • 12

    Dec

BMRN

BioMarin

$93.54

-1.12 (-1.18%)

12:29
10/18/17
10/18
12:29
10/18/17
12:29
Earnings
BioMarin sees 2017 product revenue at mid-point of guidance »

BioMarin said that at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 26

    Oct

  • 06

    Nov

  • 28

    Feb

EQT

EQT Corporation

$62.94

-0.3799 (-0.60%)

12:25
10/18/17
10/18
12:25
10/18/17
12:25
Options
EQT Corporation call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 14

    Nov

NLSN

Nielsen

$41.06

1.06 (2.65%)

, LGF

Use LGF.A, LGF.B

12:20
10/18/17
10/18
12:20
10/18/17
12:20
Hot Stocks
Nielsen to independently measure subscription-based streaming content. »

Nielsen announced that…

NLSN

Nielsen

$41.06

1.06 (2.65%)

LGF

Use LGF.A, LGF.B

DIS

Disney

$97.64

-0.7161 (-0.73%)

TWX

Time Warner

$101.12

-0.34 (-0.34%)

NFLX

Netflix

$199.48

-3.2 (-1.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 25

    Oct

  • 09

    Nov

$NSD

NASDAQ Market Internals

12:17
10/18/17
10/18
12:17
10/18/17
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
10/18/17
10/18
12:16
10/18/17
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOBL

MobileIron

$3.80

-0.1 (-2.56%)

12:10
10/18/17
10/18
12:10
10/18/17
12:10
Downgrade
MobileIron rating change  »

MobileIron downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBI

MBIA

$7.08

0.07 (1.00%)

12:10
10/18/17
10/18
12:10
10/18/17
12:10
Options
Far downside put buyer in MBIA opens a notable new position »

Far downside put buyer in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOBL

MobileIron

$3.80

-0.1 (-2.56%)

12:07
10/18/17
10/18
12:07
10/18/17
12:07
Downgrade
MobileIron rating change  »

MobileIron downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STLD

Steel Dynamics

12:06
10/18/17
10/18
12:06
10/18/17
12:06
Technical Analysis
Technical Earnings Preview: Steel Dynamics has a potential bullish pattern »

On a very long-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

DANOY

Danone

$16.67

0.3 (1.83%)

12:05
10/18/17
10/18
12:05
10/18/17
12:05
Hot Stocks
Danone names Emmanuel Faber as both Chairman and CEO »

Danone announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$199.48

-3.2 (-1.58%)

12:00
10/18/17
10/18
12:00
10/18/17
12:00
Options
Large four-way option spread in Netflix as shares slump for a second day »

Large four-way option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

12:00
10/18/17
10/18
12:00
10/18/17
12:00
General news
Treasury Action: TIPS are weaker »

Treasury Action: TIPS are…

ADBE

Adobe

$150.38

-0.08 (-0.05%)

11:55
10/18/17
10/18
11:55
10/18/17
11:55
Hot Stocks
Adobe announces acquisition of KyleBrush.com; terms not disclosed »

Adobe announces in a blog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 22

    Oct

  • 06

    Nov

GMLP

Golar LNG Partners

$22.98

-0.08 (-0.35%)

11:50
10/18/17
10/18
11:50
10/18/17
11:50
Options
Notable call write in Golar LNG Partners »

Notable call write in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:50
10/18/17
10/18
11:50
10/18/17
11:50
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

IPXL

Impax

$19.30

-0.65 (-3.26%)

11:45
10/18/17
10/18
11:45
10/18/17
11:45
Conference/Events
Impax management to meet with Deutsche Bank »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 09

    Nov

BITCOIN

Bitcoin

11:44
10/18/17
10/18
11:44
10/18/17
11:44
Hot Stocks
Bitcoin falls after release of CFTC report on virtual currencies »

The U.S. Commodity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBAY

eBay

$37.49

-0.28 (-0.74%)

, SHOP

Shopify

$98.14

1.93 (2.01%)

11:41
10/18/17
10/18
11:41
10/18/17
11:41
Earnings
On The Fly: What to watch in eBay earnings report »

eBay (EBAY) is scheduled…

EBAY

eBay

$37.49

-0.28 (-0.74%)

SHOP

Shopify

$98.14

1.93 (2.01%)

AMZN

Amazon.com

$1,009.13

2.79 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 22

    Oct

  • 26

    Oct

  • 14

    Nov

  • 18

    Mar

XOP

SPDR Oil Exploration and Production Fund

$33.41

-0.26 (-0.77%)

11:40
10/18/17
10/18
11:40
10/18/17
11:40
Options
Hefty put spread in SPDR Oil Exploration and Production ETF »

Hefty put spread in SPDR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.